Cargando…
Cinacalcet may suppress kidney enlargement in hemodialysis patients with autosomal dominant polycystic kidney disease
A massively enlarged kidney can impact quality of life of autosomal dominant polycystic kidney disease (ADPKD) patients. A recent in vitro study demonstrated that an allosteric modulator of the calcium sensing receptor decreases adenosine-3′,5′-cyclic monophosphate, an important factor for kidney en...
Autores principales: | Nakatani, Shinya, Nishide, Kozo, Okuno, Senji, Ishimura, Eiji, Kabata, Daijiro, Morioka, Fumiyuki, Machiba, Yuri, Uedono, Hideki, Tsuda, Akihiro, Shoji, Shigeichi, Inaba, Masaaki, Mori, Katsuhito, Yamakawa, Tomoyuki, Emoto, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113347/ https://www.ncbi.nlm.nih.gov/pubmed/33976330 http://dx.doi.org/10.1038/s41598-021-89480-1 |
Ejemplares similares
-
Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease Patients
por: Nakatani, Shinya, et al.
Publicado: (2020) -
Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis
por: Mori, Katsuhito, et al.
Publicado: (2019) -
Paradoxical positive association of serum adiponectin with all-cause mortality based on body composition in Japanese haemodialysis patients
por: Machiba, Yuri, et al.
Publicado: (2018) -
Short-Term Dapagliflozin Administration in Autosomal Dominant Polycystic Kidney Disease—A Retrospective Single-Arm Case Series Study
por: Morioka, Fumiyuki, et al.
Publicado: (2023) -
New-onset kidney biopsy-proven IgA vasculitis after receiving mRNA-1273 COVID-19 vaccine: case report
por: Nakatani, Shinya, et al.
Publicado: (2022)